Citi and UBS Maintain Buy Ratings on Pine Labs, Highlight Revenue CAGR and Margin Expansion Prospects 10 days ago
Citi has maintained a Buy rating on Pine Labs with a target price of ₹235, projecting an 18.5% revenue CAGR and EBITDA margin expansion from 21% in FY26 to 30% in FY28, supported by FY27 growth guidance of 21–23% and improving B2B fintech monetisation. UBS has similarly maintained a Buy rating with a target price of ₹220, highlighting GMV of ₹740bn (up 22% YoY), EMI-on-UPI rollout, AI transaction rails, and a 19% revenue CAGR over FY26–28. Both brokerages cite strong revenue growth guidance of 20%+ and margin expansion as central to their positive outlook on the stock.
Jefferies Maintains Buy on Pine Labs, Slashes Target Price to Rs 185 from Rs 260 After Q4 Miss
Jefferies maintained its Buy rating on Pine Labs while cutting the target price to Rs 185 from Rs 260 after Q4 core earnings missed estimates. Revenue grew 17% YoY with a 73% contribution margin, and adjusted EBITDA margin improved to 21% on lower opex growth and one-time gains, lifting profit to Rs 585 mn. Stronger cash flows were highlighted as a key positive. Management guided for revenue growth to accelerate to 20%+ from Q1 and 21-23% in FY27, driven by POS deployment, issuing, and affordability revenues.
Pine Labs Records ₹599.56 Crore Block Trade on NSE at ₹135.65 Per Share
A block trade worth ₹599.56 crore was recorded on the NSE for Pine Labs, involving approximately 44198998 shares at ₹135.65 per share. The transaction highlights significant large-scale activity in the stock, indicative of institutional-level participation. Block trades of this size are typically executed to facilitate large transfers of shares with minimal disruption to the open market.
Citi Initiates Buy Rating on Pine Labs with Target Price ₹235
Citi has initiated coverage on Pine Labs with a Buy rating and target price of ₹235, highlighting the company's strong leadership in merchant payments and improving monetization in India's fintech sector. The brokerage cited limited disruption risk due to profitability focus, rising regulatory barriers, sticky enterprise integrations, and stable competitive positioning as key factors supporting the positive outlook.
08Apr 26
JPMorgan Initiates Neutral Rating on Pine Labs with ₹165 Target Price
JPMorgan has initiated neutral coverage on Pine Labs with a ₹165 target price, recognizing the company's strong position in the growing digital payments market with TAM expanding at 23-25% CAGR. The firm operates an extensive network of 0.9 million merchants, 650+ brands, and 160+ institutions. While EBITDA margins are expected to improve to ~27% by FY28 through affordability and operating leverage, moderating ecosystem growth may limit revenue CAGR to ~17%, though adjusted EBITDA is projected to grow at ~34% CAGR during FY26-28.
Jefferies Maintains Buy Rating on Pine Labs, Cuts Target Price to Rs 260
Jefferies maintains its Buy rating on Pine Labs while cutting the target price to Rs 260 from Rs 300. The brokerage expects ~20% revenue growth and EBITDA margin expansion through operating leverage, network expansion, faster loan origination, and new segments. However, the stock faces near-term pressure with 20-30% YTD decline and sensitivity to lower contribution impacting adjusted EBITDA by ~9-6%.